Female bodybuilders and TRT: separating sport from medicine

What did @kenhthu6 actually say?

The video covers a lot of ground fast. One woman says she's on "just TRT from a doctor" after bloodwork revealed she needed it, and that it helped with weight she couldn't lose despite training. The creator then introduces Hunter Henderson, a competitive bodybuilder preparing for the Olympia, and states on camera: "she's definitely on steroids." Henderson herself confirms steroid use during prep, mentioning her coaches are "super health conscious" but that past coaches pushed her harder than she liked. The video closes with the creator consulting a doctoral researcher who specifically studies female steroid use.

The central thread is that women's testosterone needs are misunderstood, that female steroid use exists and is different from male use, and that the stigma women face is disproportionate. That's actually a reasonable frame, and for TikTok fitness content, it's more grounded than most.

Does the science back this up?

On TRT for women: yes, with caveats. Testosterone deficiency in women is real, underdiagnosed, and associated with symptoms including fatigue, low libido, and difficulty managing body composition. But the evidence base is thinner than it is for men, and no testosterone product is currently FDA-approved specifically for women in the United States.

A 2019 global consensus statement published in The Journal of Clinical Endocrinology and Metabolism (Wierman et al.) acknowledged that low testosterone in women is clinically meaningful, but stressed that doses should remain within physiological ranges. The woman in the video who couldn't lose weight despite training and then discovered via bloodwork she needed TRT is a plausible clinical scenario. Low testosterone in women correlates with reduced lean mass and metabolic changes, per Davis et al., 2019, Nature Reviews Endocrinology. The claim isn't wild.

On steroid use in female competitive bodybuilding: it is widespread. A 2021 survey by Gruber and Pope in The Physician and Sportsmedicine documented androgenic-anabolic steroid use among competitive female athletes across multiple sports. Virilization effects, including voice changes, clitoral enlargement, and menstrual disruption, occur at lower doses in women than men, which makes the "health-conscious coaching" point Henderson raised more than just PR spin.

What did they get wrong (or right)?

They got the stigma framing right. Research does confirm women who use performance-enhancing drugs face harsher social judgment than men, even when the drugs involved are comparable. That's not opinion, it's documented in qualitative research on female athlete drug use (Henning, 2014, International Journal of Sport Policy and Politics).

What the video glosses over: the clinical distance between therapeutic TRT and competitive steroid use is enormous. The woman using doctor-prescribed TRT to reach normal physiological levels and Hunter Henderson using steroids for Olympia prep are not on the same spectrum, but the video edits them together as if they are. This conflation matters. Therapeutic testosterone for women targets roughly 15-70 ng/dL. Competitive bodybuilding doses can push women into male-range androgens, which carry documented risks: dyslipidemia, hepatotoxicity with oral compounds, cardiovascular strain, and permanent virilization. The video doesn't distinguish these meaningfully.

The doctoral researcher cameo is promising but arrives too late and too briefly to add clinical weight. Her expertise is real, but the video doesn't actually let her say anything substantive.

What should you actually know?

If you're a woman experiencing symptoms that sound like low testosterone, a blood panel is a reasonable starting point. The challenge is that female testosterone reference ranges vary significantly by lab and life stage, and symptoms overlap with thyroid dysfunction, low estrogen, iron deficiency, and other conditions. A single testosterone number without clinical context is not a diagnosis.

Prescribed TRT for women, when dosed appropriately, has a reasonable short-term safety profile. Long-term data is weaker. The Endocrine Society recommends against routine testosterone therapy for women outside of specific indications like hypoactive sexual desire disorder, partly because the long-term cardiovascular and breast cancer risk data remains incomplete (Bhasin et al., 2019, Journal of Clinical Endocrinology and Metabolism).

For anyone considering TRT through a telehealth platform: make sure bloodwork is part of the intake process, not optional. The woman in this video did it right. She got labs first. That's the minimum standard.